“I am very excited to join the cell and gene industry leaders and shed some light on how strong partnerships can be instrumental in taking research from the lab to the clinic,” said Dr. Gincel.
TEDCO, Maryland’s economic engine for technology companies, announced its participation in this year’s Biotech Week Boston. The event is dedicated to accelerating the business of biotechnology through new ideas, science, technology and partnerships. Dr. Dan Gincel, executive director of the Maryland Stem Cell Research Fund, will be a speaker at the event’s Cell & Gene Therapy Bioprocessing & Commercialization session on September 4 at 2:30 p.m.
The four-day festival will take place at the Hynes Convention Center from Tuesday, September 4 to Friday, September 7. The conference offers leading events spanning the drug development value chain, providing access to the most inventive scientific minds and business leaders in Boston and around the world. This year’s event promises more than 500 keynotes, presentations and case studies—with more than 12 leading events, over 5,000 qualified attendees and over 37 countries represented.
“I am very excited to join the cell and gene industry leaders and shed some light on how strong partnerships can be instrumental in taking research from the lab to the clinic,” said Dr. Gincel. “I invite everyone to join our session on Public/Private Partnerships and learn more about our funding.”
Biotech Week Boston is dedicated to accelerating the business of biotechnology to make a positive impact on patient health. Guests can expect thought leaders and potential partners from several industries including financing, manufacturing and clinical trials—offering the opportunity to network with those who help shape the futures of these industries.
“Boston is a hub for innovation, especially in the life science sector. We offer the best ecosystem for growing and supporting biotech companies,” said Martin J. Walsh, Mayor of Boston. “We are America’s startup city and lead in venture capital... We are always excited for opportunities to share our work on a national and global stage.”
Maryland Stem Cell Research Fund (MSCRF) was established by the governor and the Maryland General Assembly under the Maryland Stem Cell Research Act of 2006. The purpose of the fund is to promote state-funded human stem cell research and medical treatments through grants to public and private entities in the state. For more information, please contact mscrfinfo(at)tedco.md to schedule a one-on-one, or visit http://www.mscrf.org.
Vice President for Marketing, TEDCO